Skip to content

Addiction Biology

ISSN 1355-6215, 1369-1600

68 papers in the library · 1,598 citations · publishing 1998-2026

Papers

Sort Most recent Most cited

Neurophysiological and Behavioural Effects of Combined Cannabis Concentrates and Alcohol Among People Who Regularly Use Alcohol and Cannabis.

Addiction Biology November 2026 Eleftherios M Hetelekides, Patricia L Davies, Mark A. Prince et al.

Increasingly potent concentrated cannabis products containing high levels of Δ9-tetrahydrocannabinol (THC) are being consumed with alcohol. This combination is known to acutely impair cognitive and psychomotor abilities, although few studies have evaluated alcohol and cannabis co-use using neural measures. This naturalistic feasibility study explored the acute effects of co-intoxication on...

Fentanyl, Methamphetamine and Polysubstance Use Differentially Affect Locomotor Sensitisation and Social Behaviour in Rats: Psychedelic Treatment Reverses Social Deficits.

Addiction Biology March 1, 2026 Leah M Salinsky, Kyra C Diaz, Joshua L Fox et al. 1 citation

Polysubstance use of opioids and stimulants is increasingly common among individuals with a substance use disorder, yet most researchers examine these substances in isolation. This gap limits our understanding of the effects of polysubstance use and how these differ from single substance use. Here, we examined the impact of single versus polysubstance exposure of fentanyl and methamphetamine on...

DOI: 10.1111/adb.70132 (opens in new tab) Full text (opens in new tab) Fentanyl Methamphetamine Polysubstance Psychedelic +1

Psilocybin and Ibogaine in Cocaine‐Seeking: Extinction Enhancement Without Relapse Prevention

Addiction Biology March 1, 2026 Isis Koutrouli, Vojtěch Brejtr, Marek Schwendt et al.

Psychedelics have emerged as potential therapeutics for substance use disorders, yet preclinical data validating their efficacy remain limited. Here, we investigated the effects of a clinically inspired dose-escalation protocol of psilocybin and ibogaine on extinction and cue-induced reinstatement in Wistar male rats following intravenous cocaine self-administration (IVSA). Rats were trained on...

DOI: 10.1111/adb.70111 (opens in new tab) Psilocybin Extinction optical mineralogy Hallucinogen Drug +2

Increased Mesostriatal Intrinsic Connectivity Associated With Cue Exposure in Adult Cannabis Users: Preliminary Findings.

Addiction Biology August 1, 2025 Natalia M Kleinhans, Garth E Terry, Dahyeon Kang et al.

Cue-induced craving-the desire to use a drug triggered by exposure to cues associated with prior use-is a central mechanism in the development and maintenance of problematic substance use behaviours. Drug cues have the power to induce craving even in long-term abstinent individuals, which has led clinicians to advise patients to avoid the people, places and objects that are associated with...

Treadmill Exercise Training Ameliorates Apoptotic Cells and DNA Oxidation in the Cerebral Cortex of Rats Exposed to Chronic Ketamine Abuse.

Addiction Biology March 1, 2025 Salar Sabziparvar, Kazem Khodaei, Javad Tolouei Azar 1 citation

Ketamine abuse damages brain function and structure, increasing reactive oxygen species and apoptosis in the cerebral cortex, but moderate-intensity continuous training (MICT) can enhance antioxidant defences and reduce apoptosis. Therefore, we aimed to answer whether MICT can reduce the side effects of chronic ketamine abuse. 24 Wistar rats were split into control (CON), ketamine abuse (KET),...

Altered Functional Connectivity Dynamics Serving Cognitive Flexibility in Regular Cannabis Users.

Addiction Biology February 1, 2025 Kellen M McDonald, Mikki Schantell, Jason A John et al.

Despite its widespread use and popularity, cannabis is known to impact higher order cognitive processes such as attention and executive function. However, far less is known about the impact of chronic cannabis use on cognitive flexibility, a component of executive function, and this is especially true for the underlying functional connectivity dynamics. To address this, we enrolled 25 chronic...

DOI: 10.1111/adb.70023 (opens in new tab) Full text (opens in new tab) Meg Attention network Magnetoencephalography Oscillations +1

The potential of 5‐methoxy‐N,N‐dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action

Addiction Biology April 1, 2024 Stephan Tap 12 citations

Abstract Alcohol use disorder (AUD) remains one of the most prevalent psychiatric disorders worldwide with high economic costs. Current treatment options show modest efficacy and relapse rates are high. Furthermore, there are increases in the treatment gap and few new medications have been approved in the past 20 years. Recently, psychedelic‐assisted therapy with psilocybin and lysergic acid...

Δ9 -Tetrahydrocannabinol self-administration induces cell type-specific adaptations in the nucleus accumbens core.

Addiction Biology August 2023 Constanza Garcia-Keller, Madeline Hohmeister, Kailyn Seidling et al.

Drugs of abuse induce cell type-specific adaptations in D1- and D2-medium spiny neurons (MSNs) in the nucleus accumbens core (NAcore) that can bias signalling towards D1-MSNs and enhance relapse vulnerability. Whether Δ9 -tetrahydrocannabinol (THC) use initiates similar neuroadaptations is unknown. D1- and D2-Cre transgenic rats were transfected with Cre-dependent reporters and trained to...

Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies

Addiction Biology August 31, 2022 Elena Giné, Javier Calleja‐conde, José Á. Morales-García et al. 49 citations

Abstract Classic psychedelics refer to substances such as lysergic acid diethylamide (LSD), psilocybin, ayahuasca, and mescaline, which induce altered states of consciousness by acting mainly on 5‐HT 2A receptors. Recently, the interest of psychedelics as pharmacological treatment for psychiatric disorders has increased significantly, including their use on problematic use of alcohol. This...

DOI: 10.1111/adb.13229 (opens in new tab) Human studies Animal studies

Pharmacokinetics, systemic toxicity, thermoregulation and acute behavioural effects of 25CN‐NBOMe

Addiction Biology August 4, 2022 Klára Šíchová, Kateřina Syrová, Edita Kofroňová et al. 8 citations

agonists containing substances emerging on the illicit drug market as a replacement for N,N-diethyllysergamide (LSD). Despite the increasing use of NBOMes for diagnostic, research and recreational purposes, only a limited number of studies have focussed on their in vivo effect. Here, we investigated pharmacokinetics, systemic toxicity, thermoregulation in individually and group-housed animals,...

DOI: 10.1111/adb.13216 (opens in new tab) Thermoregulation Pharmacology Acute toxicity Pharmacokinetics

2-Fluorodeschloroketamine has similar abuse potential as ketamine.

Addiction Biology May 1, 2022 Feng Li, Han Du, Bo Wu et al. 16 citations

2-Fluorodeschloroketamine (2-FDCK) as a substitute for ketamine has emerged among drug abusers in recent years. However, 2-FDCK has not been controlled or regulated in many countries, which may be partly related to the lack of evidence on its abuse potential. In this study, we evaluated the abuse potential of 2-FDCK via the tests of the conditioned place preference (CPP), locomotor...

DOI: 10.1111/adb.13171 (opens in new tab) Full text (opens in new tab) 2-fluorodeschloroketamine Conditioned place preference Drug discrimination Drug self-administration +1

Changes in brain structure and function following chronic exposure to inhaled vaporised cannabis during periadolescence in female and male mice: A multimodal MRI study.

Addiction Biology May 2022 James R Coleman, Dan Madularu, Richard J. Ortiz et al.

Social norms and legality surrounding the use of medical and recreational cannabis are changing rapidly. The prevalence of cannabis use in adolescence is increasing. The aim of this study was to assess any sex-based neurobiological effects of chronically inhaled, vaporised cannabis on adolescent female and male mice. Female and male mice were exposed daily to vaporised cannabis (10.3%...

DOI: 10.1111/adb.13169 (opens in new tab) Full text (opens in new tab) Marijuana Cb1 Diffusion weighted imaging Endocannabinoid +2

Repeated low doses of LSD in healthy adults: A placebo-controlled, dose-response study.

Addiction Biology February 1, 2022 Harriet de Wit, Hanna Molla, Anya K. Bershad et al. 82 citations

The resurgence of interest in using psychedelic drugs, including lysergic acid diethylamide (LSD), in psychiatry has drawn attention to the medically unsupervised practice of 'microdosing'. Thousands of users claim that very low doses of LSD, taken at 3-4-day intervals, improve mood and cognitive function., However, few controlled studies have described the effects of the drug when taken in...

DOI: 10.1111/adb.13143 (opens in new tab) Full text (opens in new tab) LSD Microdosing Mood and cognition Clinical research

Effects of cannabidiol in cannabis flower: Implications for harm reduction.

Addiction Biology 2022 Laurel P Gibson, Hollis C Karoly, Jarrod M. Ellingson et al.

Using a federally compatible, naturalistic at-home administration procedure, the present study examined the acute effects of three cannabis flower chemovars with different tetrahydrocannabinol (THC) to cannabidiol (CBD) ratios, in order to test whether chemovars with a higher CBD content produce different effects. Participants were randomly assigned to ad libitum administration of one of three...

Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials

Addiction Biology December 22, 2021 Thomas R. Arkell, Richard C. Kevin, Frederick Vinckenbosch et al. 45 citations

Some evidence suggests that males and females may differ in their responses to acute cannabis effects, including subjective drug effects and behavioural effects, and cannabinoid pharmacokinetics. This is significant given current changes to cannabis-related policies and, in consequence, increased cannabis accessibility. The present study combines data from two randomized controlled trials to...

DOI: 10.1111/adb.13125 (opens in new tab) Cannabidiol Randomized controlled trial Effects of cannabis Cannabis dependence +1

Multimodal MRI data fusion reveals distinct structural, functional and neurochemical correlates of heavy cannabis use

Addiction Biology November 22, 2021 Dusan Hirjak, Mike M. Schmitgen, Florian Werler et al. 33 citations

Heavy cannabis use (HCU) is frequently associated with a plethora of cognitive, psychopathological and sensorimotor phenomena. Although HCU is frequent, specific patterns of abnormal brain structure and function underlying HCU in individuals presenting without cannabis-use disorder or other current and life-time major mental disorders are unclear at present. This multimodal magnetic resonance...

The dopaminergic alterations induced by 4‐F‐PCP and 4‐Keto‐PCP may enhance their drug‐induced rewarding and reinforcing effects: Implications for abuse

Addiction Biology July 1, 2021 Darlene Mae Ortiz, Raly James Perez Custodio, Arvie Abiero et al.

Abstract: Novel psychoactive substances remain the popular recreational drugs of use over the years. They continue to bypass government restrictions due to their synthesis and modifications. Recent additions to the lists are the 4‐F‐PCP and 4‐Keto‐PCP, analogs of the drug phencyclidine (PCP) known to induce adverse effects and abuse potential. However, studies on the abuse potential of 4‐F‐PCP...

Optogenetic brain‐stimulation reward: A new procedure to re‐evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter‐Cre mice

Addiction Biology February 3, 2021 Bree A. Humburg, Chloe J. Jordan, Hai‐Ying Zhang et al. 30 citations

Abstract Despite extensive research, the rewarding effects of cannabinoids are still debated. Here, we used a newly established animal procedure called optogenetic intracranial self‐stimulation (ICSS) (oICSS) to re‐examine the abuse potential of cannabinoids in mice. A specific adeno‐associated viral vector carrying a channelrhodopsin gene was microinjected into the ventral tegmental area (VTA)...

DOI: 10.1111/adb.13005 (opens in new tab) Full text (opens in new tab) Cannabidiol Ventral tegmental area Optogenetics Brain stimulation reward +8

25B-NBOMe, a novel N-2-methoxybenzyl-phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: Evidence of abuse potential

Addiction Biology November 1, 2020

Abstract An increasing number of N ‐2‐methoxybenzyl‐phenethylamine (NBOMe) derivatives are being misused worldwide, including the potent hallucinogen 2‐(4‐bromo‐2,5‐dimethoxyphenyl)‐ N ‐(2‐methoxybenzyl)ethanamine (25B‐NBOMe). However, the number of studies characterizing the abuse potential and psychopharmacological properties of 25B‐NBOMe is limited; thus, we examined its rewarding and...

The loss of NMDAR-dependent LTD following cannabinoid self-administration is restored by positive allosteric modulation of CB1 receptors.

Addiction Biology November 2020 Daniela Neuhofer, Sade M Spencer, Vivian C Chioma et al.

Glutamatergic plasticity in the nucleus accumbens core (NAcore) is a key neuronal process in appetitive learning and contributes to pathologies such as drug addiction. Understanding how this plasticity factors into cannabis addiction and relapse has been hampered by the lack of a rodent model of cannabis self-administration. We used intravenous self-administration of two constituents of...

Regional changes in ∆FosB expression in rat brain following MDMA self‐administration predict increased sensitivity to effects of locally infused MDMA

Addiction Biology September 1, 2020 Ross Van de Wetering, Susan Schenk 9 citations

AbstractRepeated exposure to drugs produces a plethora of persistent brain changes, some of which underlie the development of drug addiction. An important objective of addiction research is to identify the brain changes that might mediate the transition from drug use to drug misuse. The persistent accumulation of the transcription factor, ∆FosB, following repeated drug exposure provides a means...

Effects of 5-HT2A Receptor Stimulation on Economic Demand for Fentanyl after Intermittent and Continuous Access Self-Administration in Male Rats

Addiction Biology May 26, 2020 David Martin, Utsav Gyawali, Donna J. Calu

The relative value of and motivation for abused drugs often increases with drug experience and differs based on drug availability. Here, we determined how different intake patterns of fentanyl, a μ‐opioid agonist, alter economic demand for fentanyl and how 5‐HT2A receptor stimulation affects economic demand for fentanyl. We used a within‐session demand threshold procedure to characterize...

Naphyrone (naphthylpyrovalerone): Pharmacokinetics, behavioural effects and thermoregulation in Wistar rats

Addiction Biology May 7, 2020 Nikola Pinterová, Rachel R. Horsley, Hynek Danda et al. 13 citations

Naphthylpyrovalerone (naphyrone) is a pyrovalerone cathinone that potently inhibits monoamine transporters and provides stimulatory-entactogenic effects. Little is known about the safety of naphyrone or its effects in vivo, and more research is needed to acquire knowledge about its fundamental effects on physiology and behaviour. Our objective was to investigate naphyrone's pharmacokinetics,...

DOI: 10.1111/adb.12906 (opens in new tab) Pharmacokinetics Pharmacology Open field In vivo +4

Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic users

Addiction Biology December 22, 2019 Natasha L. Mason, Eef L. Theunissen, Nadia R. P. W. Hutten et al. 58 citations

Cannabis is the most commonly used illicit drug in the world. However, because of a changing legal landscape and rising interest in therapeutic utility, there is an increasing trend in (long-term) use and possibly cannabis impairment. Importantly, a growing body of evidence suggests that regular cannabis users develop tolerance to the impairing, as well as the rewarding, effects of the drug....

DOI: 10.1111/adb.12870 (opens in new tab) Cannabidiol Context archaeology Dronabinol Effects of cannabis +4

Synergistic effects of marijuana abuse and HIV infection on neural activation during a cognitive interference task.

Addiction Biology November 2019 Christina S Meade, Ryan P Bell, Sheri L Towe et al.

Marijuana use, which is disproportionately prevalent among human immunodeficiency virus (HIV)-infected persons, can alter activity in fronto-parietal regions during cognitively demanding tasks. While HIV is also associated with altered neural activation, it is not known how marijuana may further affect brain function in this population. Our study examined the independent and additive effects of...